Litcius/Paper detail

Nanomedicine of tyrosine kinase inhibitors

Veronika Šmídová, Petr Michálek, Zita Goliášová, Tomáš Eckschlager, Petr Hodek, Vojtěch Adam, Zbyněk Heger

2020Theranostics47 citationsDOIOpen Access PDF

Abstract

for simultaneous therapeutic and diagnostic purposes. The review provides a comprehensive overview of advantages and future prospects of conjunction of nanotransporters with TKIs as a highly promising approach to anticancer therapy.

Topics & Concepts

NanomedicineNanocarriersMedicineDrugDrug deliveryPharmacologyTyrosine kinaseAdverse effectClinical trialNanotechnologyMaterials scienceInternal medicineReceptorNanoparticleNanoparticle-Based Drug DeliverySynthesis of Tetrazole DerivativesMonoclonal and Polyclonal Antibodies Research
Nanomedicine of tyrosine kinase inhibitors | Litcius